Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
Immunotherapy of multiple myeloma
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
[Addition of hyperthermia. Heat potentiates cancer therapy]
The use of dendritic cells in cancer therapy
The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors
Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects
Localised spontaneous regression in mesothelioma — possible immunological mechanism
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
Dendritic cells for specific cancer immunotherapy
Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
Dendritic cells and chronic hepatitis virus carriers
Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report